首页> 外文期刊>International Current Pharmaceutical Journal >Process optimisation, characterisation and evaluation of resveratrol-phospholipid complexes using Box-Behnken statistical design
【24h】

Process optimisation, characterisation and evaluation of resveratrol-phospholipid complexes using Box-Behnken statistical design

机译:使用Box-Behnken统计设计对白藜芦醇-磷脂复合物进行工艺优化,表征和评估

获取原文
           

摘要

With the advent of 21st century, researchers worldwide have extensively reviewed herbs and botanicals for their marked clinical efficacy. It has been estimated that most of the newly discovered compounds offer poor bioavailability due to their low aqueous solubility. Phospholipid complexation of the drug often helps to improve its water solubility and enhance the bioavailability. This study includes optimization of resveratrol-phospholipid complexes using a 3-factor, 3-level box-behnken design (15 batches). Three independent variables i.e. phospholipid-resveratrol ratio, refluxing temperature and reflux time were optimized for two dependent variables, i.e. yield and entrapment efficiency (EE). Complexes were prepared by refluxing stoichiometric ratio of Phospholipon 90G and resveratrol in dichloromethane and retrieved by precipitation with n-hexane. Complexation was confirmed by Fourier Transform Infra-Red (FTIR) spectroscopy. The data was suitably used to explore quadratic response surfaces and construct second order polynomial models with Design Expert?. Formulation with highest desirability (D=0.994) was selected as optimum and prepared using 1.5:1 Phospholipon 90G-resveratrol ratio (X1) at 59.4°C temperature (X2) and 4 h time (X3) to give maximum yield and entrapment efficiency. Analysis of variance (ANOVA) was also found to be significant for both the responses.?Complexes were optimised for good yield and EE. The partition coefficient was lowered to 2.25 hypothesizing good passive absorption.DOI:?http://dx.doi.org/10.3329/icpj.v3i7.19079 International Current Pharmaceutical Journal, June 2014, 3(7): 301-308
机译:随着21世纪的到来,全世界的研究人员对草药和植物药的显着临床功效进行了广泛的审查。据估计,大多数新发现的化合物由于其低的水溶性而提供了较差的生物利用度。药物的磷脂络合通常有助于改善其水溶性并提高生物利用度。这项研究包括使用3因子,3级Box-Behnken设计(15批次)优化白藜芦醇-磷脂复合物。针对两个因变量(即收率和包封效率(EE))优化了三个自变量,即磷脂-白藜芦醇比率,回流温度和回流时间。通过在二氯甲烷中回流化学计量比的磷脂90G和白藜芦醇来制备复合物,并通过用正己烷沉淀来回收。通过傅立叶变换红外(FTIR)光谱法证实了络合。该数据适合用于探索二次响应面并使用Design Expert?构建二阶多项式模型。选择具有最高期望值(D = 0.994)的配方为最佳配方,并在59.4°C温度(X2)和4小时(X3)下使用1.5:1磷脂90G-白藜芦醇比率(X1)进行制备,以提供最大的收率和包封效率。还发现方差分析(ANOVA)对这两个响应均具有重要意义。对复合物进行了优化,以提高产量和EE。假设良好的被动吸收,分配系数降低至2.25.DOI:?http://dx.doi.org/10.3329/icpj.v3i7.19079 International Current Pharmaceutical Journal,2014年6月,3(7):301-308

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号